SCHEMBL5335628

SCHEMBL5335628

CC(C)(C)OC(=O)Cc1ccc(F)cc1C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 5/20 0.46
MTNR1B P49286 5/20 0.46
KEAP1 Q14145 1/20 0.42
RORC P51449 1/20 0.38
MAOB P27338 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
RIPK1 Q13546 2/20 0.35
CES2 O00748 1/20 0.35
CES1 P23141 1/20 0.35
GABRA1 P14867 1/20 0.34
GABRG2 P18507 1/20 0.34
GABRB3 P28472 1/20 0.34
GABRA5 P31644 1/20 0.34
GABRA3 P34903 1/20 0.34
GABRA2 P47869 1/20 0.34
GABRA4 P48169 1/20 0.34
GABRA6 Q16445 1/20 0.34
DHODH Q02127 1/20 0.34
DCLRE1B Q9H816 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2528222 0.86 MTNR1A (0.47) MTNR1AMTNR1BGABRA1GABRG2GABRB3
SCHEMBL31502416 0.82 MTNR1A (0.46) MTNR1AMTNR1B
SCHEMBL11777759 0.81 KEAP1 (0.50) KEAP1MAOBCES2CES1DHODH
SCHEMBL16410342 0.81 MTNR1A (0.47) MTNR1AMTNR1BKEAP1RORCMAOB
SCHEMBL25972059 0.80 MTNR1A (0.56) MTNR1AMTNR1BRORCMAOBSMN1; SMN2
SCHEMBL27708142 0.79 MTNR1A (0.49) MTNR1AMTNR1BRORCMAOBSMN1; SMN2
SCHEMBL1654700 0.79 KDM4A (0.42) KEAP1
SCHEMBL20681234 0.78 MTNR1A (0.45) MTNR1AMTNR1BRORCMAOBRIPK1
SCHEMBL16410276 0.78 MTNR1A (0.50) MTNR1AMTNR1BKEAP1RORCMAOB
SCHEMBL29805288 0.78 MTNR1A (0.50) MTNR1AMTNR1BKEAP1RORCMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007064619-A1 PYRIMIDINE DERIVATIVES AS HIV INTEGRASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-06-07 WO disclosed